85 related articles for article (PubMed ID: 14761530)
1. [Effect of aberrant DNA methylation on the expression of cancer-related genes in Cd-transformed cells].
Lei YX; Joseph P; Wu ZL; Ong TM
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2003 Apr; 21(2):114-6. PubMed ID: 14761530
[TBL] [Abstract][Full Text] [Related]
2. Identification of DNA methylation markers for human breast carcinomas using the methylation-sensitive restriction fingerprinting technique.
Huang TH; Laux DE; Hamlin BC; Tran P; Tran H; Lubahn DB
Cancer Res; 1997 Mar; 57(6):1030-4. PubMed ID: 9067264
[TBL] [Abstract][Full Text] [Related]
3. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H
Digestion; 2007; 75(1):54-61. PubMed ID: 17438355
[TBL] [Abstract][Full Text] [Related]
4. Identification of 27 5' CpG islands aberrantly methylated and 13 genes silenced in human pancreatic cancers.
Hagihara A; Miyamoto K; Furuta J; Hiraoka N; Wakazono K; Seki S; Fukushima S; Tsao MS; Sugimura T; Ushijima T
Oncogene; 2004 Nov; 23(53):8705-10. PubMed ID: 15467763
[TBL] [Abstract][Full Text] [Related]
5. Methylation of tumor suppressor genes p16(INK4a), p27(Kip1) and E-cadherin in carcinogenesis.
Auerkari EI
Oral Oncol; 2006 Jan; 42(1):5-13. PubMed ID: 15978859
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia.
Gebhard C; Schwarzfischer L; Pham TH; Schilling E; Klug M; Andreesen R; Rehli M
Cancer Res; 2006 Jun; 66(12):6118-28. PubMed ID: 16778185
[TBL] [Abstract][Full Text] [Related]
7. Rapid and sensitive detection of CpG-methylation using methyl-binding (MB)-PCR.
Gebhard C; Schwarzfischer L; Pham TH; Andreesen R; Mackensen A; Rehli M
Nucleic Acids Res; 2006 Jul; 34(11):e82. PubMed ID: 16822855
[TBL] [Abstract][Full Text] [Related]
8. Analysis of aberrant methylation in DNA repair genes during malignant transformation of human bronchial epithelial cells induced by cadmium.
Zhou ZH; Lei YX; Wang CX
Toxicol Sci; 2012 Feb; 125(2):412-7. PubMed ID: 22112500
[TBL] [Abstract][Full Text] [Related]
9. Denaturing high-performance liquid chromatography (DHPLC) as a reliable high-throughput prescreening method for aberrant promoter methylation in cancer.
Betz B; Florl AR; Seifert HH; Dall P; Schulz WA; Niederacher D
Hum Mutat; 2004 Jun; 23(6):612-20. PubMed ID: 15146466
[TBL] [Abstract][Full Text] [Related]
10. [Effects of inorganic arsenicals on the methylation of p16 gene CpG islands and the expression of p16 gene in BEP2D cells].
Lu G; Cai Q; Zhang W
Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(20):1238-41. PubMed ID: 11825526
[TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide induces aberrant hypermethylation of Hic-1 in mouse embryonic fibroblasts lacking p53 gene.
Tatemichi M; Hata H; Tazawa H; Nakadate T
Anticancer Res; 2008; 28(4B):2101-8. PubMed ID: 18751382
[TBL] [Abstract][Full Text] [Related]
12. Relationship of the aberrant DNA hypermethylation of cancer-related genes with carcinogenesis of endometrial cancer.
Banno K; Yanokura M; Susumu N; Kawaguchi M; Hirao N; Hirasawa A; Tsukazaki K; Aoki D
Oncol Rep; 2006 Dec; 16(6):1189-96. PubMed ID: 17089036
[TBL] [Abstract][Full Text] [Related]
13. Multiple tumor suppressor genes are increasingly methylated with age in non-neoplastic gastric epithelia.
So K; Tamura G; Honda T; Homma N; Waki T; Togawa N; Nishizuka S; Motoyama T
Cancer Sci; 2006 Nov; 97(11):1155-8. PubMed ID: 16952303
[TBL] [Abstract][Full Text] [Related]
14. A NotI-EcoRV promoter library for studies of genetic and epigenetic alterations in mouse models of human malignancies.
Yu L; Liu C; Bennett K; Wu YZ; Dai Z; Vandeusen J; Opavsky R; Raval A; Trikha P; Rodriguez B; Becknell B; Mao C; Lee S; Davuluri RV; Leone G; Van den Veyver IB; Caligiuri MA; Plass C
Genomics; 2004 Oct; 84(4):647-60. PubMed ID: 15475242
[TBL] [Abstract][Full Text] [Related]
15. Identification of PRTFDC1 silencing and aberrant promoter methylation of GPR150, ITGA8 and HOXD11 in ovarian cancers.
Cai LY; Abe M; Izumi S; Imura M; Yasugi T; Ushijima T
Life Sci; 2007 Mar; 80(16):1458-65. PubMed ID: 17303177
[TBL] [Abstract][Full Text] [Related]
16. Gene silencing by DNA methylation in haematological malignancies.
Boultwood J; Wainscoat JS
Br J Haematol; 2007 Jul; 138(1):3-11. PubMed ID: 17489980
[TBL] [Abstract][Full Text] [Related]
17. A mouse skin multistage carcinogenesis model reflects the aberrant DNA methylation patterns of human tumors.
Fraga MF; Herranz M; Espada J; Ballestar E; Paz MF; Ropero S; Erkek E; Bozdogan O; Peinado H; Niveleau A; Mao JH; Balmain A; Cano A; Esteller M
Cancer Res; 2004 Aug; 64(16):5527-34. PubMed ID: 15313885
[TBL] [Abstract][Full Text] [Related]
18. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
Lu CY; Hsieh SY; Lu YJ; Wu CS; Chen LC; Lo SJ; Wu CT; Chou MY; Huang TH; Chang YS
Genes Chromosomes Cancer; 2009 Dec; 48(12):1057-68. PubMed ID: 19760608
[TBL] [Abstract][Full Text] [Related]
19. High-throughput method for detecting DNA methylation.
Hou P; Ji M; Li S; He N; Lu Z
J Biochem Biophys Methods; 2004 Aug; 60(2):139-50. PubMed ID: 15262448
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic silencing of O6-methylguanine DNA methyltransferase gene in NiS-transformed cells.
Ji W; Yang L; Yu L; Yuan J; Hu D; Zhang W; Yang J; Pang Y; Li W; Lu J; Fu J; Chen J; Lin Z; Chen W; Zhuang Z
Carcinogenesis; 2008 Jun; 29(6):1267-75. PubMed ID: 18204074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]